Stocks and Investing Stocks and Investing
Thu, October 6, 2022
Wed, October 5, 2022
Tue, October 4, 2022
Mon, October 3, 2022

Bill Sutherland Maintained (AMED) at Strong Buy with Decreased Target to $135 on, Oct 3rd, 2022


Published on 2024-10-27 23:10:49 - WOPRAI, Bill Sutherland
  Print publication without navigation


Bill Sutherland of Benchmark, Maintained "Amedisys, Inc." (AMED) at Strong Buy with Decreased Target from $165 to $135 on, Oct 3rd, 2022.

Bill has made no other calls on AMED in the last 4 months.



There are 9 other peers that have a rating on AMED. Out of the 9 peers that are also analyzing AMED, 3 agree with Bill's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Tao Qiu of "Stifel" Initiated at Hold and Held Target at $128 on, Wednesday, June 29th, 2022
  • Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $107 on, Tuesday, June 21st, 2022
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $125 on, Tuesday, June 21st, 2022


These are the ratings of the 6 analyists that currently disagree with Bill


  • Andrew Mok of "UBS" Downgraded from Hold to Strong Sell and Decreased Target to $95 on, Tuesday, August 2nd, 2022
  • John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $140 on, Monday, August 1st, 2022
  • Sarah James of "Barclays" Maintained at Buy with Decreased Target to $154 on, Friday, July 29th, 2022
  • David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $150 on, Thursday, July 14th, 2022
  • Joanna Gajuk of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $102 on, Tuesday, June 21st, 2022
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, June 21st, 2022